http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2660642-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df91b83742bcb8697bc96f405f4b8e8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate | 2013-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b0bf13a045c69a3e9c7faa39478ca15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5b6c1e846ef64c53e0c576acf6e2b3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adbc9dc7f71b72d6ef0173b75ac8044b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d0122060d119d5049e5a3951b0c0254 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_252eb98d7ac07a90b7eeb13edffe914a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4fe9358aeb6f828e3958ed66d665cda9 |
| publicationDate | 2018-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2660642-T3 |
| titleOfInvention | Crystalline forms of dihydropyrimidine derivatives |
| abstract | A crystalline form of the compound of Formula (I): ** (See formula) ** or a tautomer, where the crystalline form is Form B, which has a powder X-ray diffraction pattern (XRPD) comprising peaks expressed in degrees 2θ at 6.68 ° ± 0.2 °, 13.39 ° ± 0.2 °, 19.65 ° ± 0.2 °, 20.26 ° ± 0.2 °, 22.45 ° ± 0.2 °, 24.80 ° ± 0.2 °, 25.01 ° ± 0.2 °, 26.19 ° ± 0.2 °, 26.61 ° ± 0.2 ° and 28.79 ° ± 0.2 °; or where the crystalline form is Form C, which has a powder X-ray diffraction pattern (XRPD) comprising peaks expressed in degrees 2θ at 5.39 ° ± 0.2 °, 13.25 ° ± 0, 2nd, 16.00 ° ± 0.2 °, 17.27 ° ± 0.2 °, 21.33 ° ± 0.2 °, 21.92 ° ± 0.2 °, 22.53 ° ± 0, 2nd, 23.47 ° ± 0.2 °, 26.56 ° ± 0.2 °, 26.87 ° ± 0.2 °, 29.41 ° ± 0.2 ° and 32.22 ° ± 0, 2nd; or where the crystalline form is Form H, which has a powder X-ray diffraction pattern (XRPD) comprising peaks expressed in degrees 2θ at 7.58 ° ± 0.2 °, 10.29 ° ± 0, 2nd, 12.00 ° ± 0.2 °, 19.07 ° ± 0.2 °, 19.93 ° ± 0.2 °, 20.78 ° ± 0.2 °, 21.33 ° ± 0, 2nd, 21.48 ° ± 0.2 °, 24.76 ° ± 0.2 °, 25.59 ° ± 0.2 °, 25.82 ° ± 0.2 °, 26.01 ° ± 0, 2nd and 26.58 ° ± 0.2 °; or where the crystalline form is Form I, which has a powder X-ray diffraction pattern (XRPD) comprising peaks expressed in degrees 2θ to 9.41 ° ± 0.2 °, 17.59 ° ± 0, 2nd, 21.37 ° ± 0.2 °, 21.72 ° ± 0.2 °, 22.15 ° ± 0.2 °, 22.50 ° ± 0.2 °, 23.90 ° ± 0, 2nd, 24.59 ° ± 0.2 °, 24.99 ° ± 0.2 °, 26.32 ° ± 0.2 °, 27.09 ° ± 0.2 °, 29.68 ° ± 0, 2nd and 30.53 ° ± 0.2 °. |
| priorityDate | 2012-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 35.